Treating and preventing malaria in children. A bibliographic review;Prise en charge du paludisme de l'enfant, y compris la prevention. Analyse de la bibliographie restreinte a la pediatrie

Medecine et Maladies Infectieuses

Volumn 29, Issue SUPPL. 2, 1999, Pages

  Banerjee, A ^a  

^a Hôpital du Perpétuel Secours   (France)

Author keywords

Imported malaria; Pediatric cerebral malaria

Indexed keywords

AMODIAQUINE; CHLOROQUINE; FANSIDAR; HALOFANTRINE; MEFLOQUINE; QUININE;

BRAIN MALARIA; CARDIOTOXICITY; CHEMOPROPHYLAXIS; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALARIA FALCIPARUM; PLASMODIUM FALCIPARUM; PREVALENCE; PRIMARY PREVENTION;

EID: 0032763171     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-077X(00)87128-0     Document Type: Conference Paper

References (133)

1. World Health Organization - OMS Genève. Wkly Epidemiol Rec 1997 ; 5 sept.
2. Legros F, Danis M, Gay F, Gentilini M. Paludisme en France métropolitaine en 1997. Bull CNRMI 1998 ; 14 : 1-63.
3. Lagardère B. Paludisme d'importation. Pédiatrie 1990; 45 (suppl) : 283-6.
4. Bégué P, Ayivi B, Quinet B, Ter Sakarian M. Le paludisme d'importation chez l'enfant : analyse épidémiologique, clinique et thérapeutique. Bull Soc Pathol Exot 1991 ; 84 : 154-63.
5. Piarroux R, Dumon H, Garnier JM, Lehmann M, Unal D, Quilici M. Choice of therapy for imported cases of falciparum malaria in children: a retrospective study of 100 cases seen in Marseille, France. Trans R Soc Trop Med Hyg 1993 ; 87 : 72-4.
6. Blasco G, Hovette P, Thibaud P, De Quincenet G, Debonne JM, Touze JE, et al. Le paludisme à Plasmodium falciparum chez les Français résidant à Yaoundé. Bull Soc Pathol Exot 1992 ; 85 : 281-4.
7. Gazin P. Difficultés du diagnostic et du traitement des accès palustres chez les Européens vivant au Burkina Faso. Bull Soc Pathol Exot 1993 ; 86 : 363-4.
8. Rivera-Matos IR, Atkins JT, Doerr CA, White AC. Pediatric malaria in Houston, Texas. Am J Trop Med Hyg 1997 ; 57 : 560-3.
9. Mac Caslin RI, Pikis A, Rodriguez WJ. Pediatric Plasmodium falciparum malaria: a ten years experience from Washington DC. Pediatr Infect Dis J 1994 ; 13 : 709-15.
10. Emmanuel B, Aronson N, Shulman S. Malaria in children in Chicago. Pediatrics 1993 ; 92 : 83-5.
11. Lynk A, Gold R. Review of 40 children with imported malaria. Pediatr Infect Dis J 1989 ; 8 : 745-50.
12. Brabin BJ, Ganley Y. Imported malaria in children in the UK. Arch Dis Child 1997 ; 77 : 76-81.
13. Kyriacou DN, Spira AM, Talan DA, Mabey DC. Emergency department presentation and misdiagnosis of imported falciparum malaria. Ann Emerg Med 1996 ; 27 : 696-9.
14. Gendrel D. Paludisme de l'enfant. À suspecter chez tout enfant fébrile au retour d'une zone d'endémie. Rev Prat Méd Gale 1994 ; 8 (272) : 35-40.
15. Riordan FAI, Tarlow MJ. Imported infection in East Birmingham children. Postgrad Med J 1998 ; 74 : 36-7.
16. Gouyon JB, Aujard Y, Jacqz E, Schlegel N, Helias JP, Pascal A. Un cas parisien de paludisme congénital. Arch Fr Pédiatr 1986 ; 43 : 201-2.
17. Hulbert TV. Congenital malaria in the United States: report of a case and review. Clin Infect Dis 1992 ; 14 : 922-6.
18. Richaud J, Canet J, Janaud JC, Leraillez J, Bouhanna A, Danan C. Paludisme post-transfusionnel chez un nourrisson de deux mois. Arch Fr Pédiatr 1982 ; 39 : 161-3.
19. Schulman IA, Saxena S, Nelson JM, Furmanski M. Neonatal exchange transfusions complicated by transfusion-induced malaria. Pediatrics 1984 ; 73 : 330-2.
20. Gendrel D, Kombila M, Gendrel C, Djouba F, Nardou M, Richard-Lenoble D. Protection against Plasmodium falciparum infection in children with hemoglobin S. Pediatr Infect Dis J 1991 ; 10: 620-1.
21. Allen SJ, O'Donnel LA, Alexander NDE, Alpers MP, Peto TEA, Clegg JB, et al. Alpha-thalassemia protects children against disease caused by other infections as well as malaria. Proc Natl Acad Sci USA 1997 ; 94 : 14736-41.
22. Pasvol G, Weatherall DJ, Wilson RJM, Smith DH, Gilles HM. Fetal haemoglobin and malaria. Lancet 1976 ; 1 : 1269-72.
23. Ruwende C, Khoo SC, Snow RW, Yates SNR, Kwiatkowski D, Gupta S, et al. Natural selection of hemi-and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature ; 376 : 246-9.
24. Warrell DA, Molyneux ME, Beasles PF. Severe and complicated malaria. Trans R Soc Trop Med Hyg 1990 ; 84 Suppl 2 : 1-65.
25. Newton CRJC, Krishna S. Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol Ther 1998 ; 79 : 1-53.
26. Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley M, Marsh V, et al. Indicators of life-threatening malaria in African children. N Eng J Med 1995 ; 332 : 399-404.
27. Molyneux ME, Taylor TE, Wirima JJ, Borgstein A. Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose malawian children. Q J Med 1989 ; 71 : 441-59.
28. Waller D, Krishna S, Crawley J, Miller K, Nosten F, Chapman D, et al. Clinical features and outcome of severe malaria in Gambian children. Clin Infect Dis 1995 ; 21 : 577-87.
29. Dieu-Osika S. Neuropaludisme ou accès pernicieux. Med Enf 1996 ; 16 : 409-11.
30. Crawley J, Smith S, Kirkham F, Muthinji P, Waruiru C, Marsh K. Seizures and status epilepticus in childhood cerebral malaria. Q J Med 1996 ; 89 : 591-7.
31. Miller LH, Good MF, Milon G. Malaria pathogenesis. Science 1994 ; 264 : 1878-83.
32. Gendrel D, Heurtaut P, Kombila M, Vinand P, Nardou M, Galliot A, et al. Crises convulsives hyperpyrétiques et paludisme de l'enfant. Ann Pédiat 1984 ; 31 : 703-4.
33. Wattanagoon Y, Srivilairit S, Looareeasuwan S, White NJ. Convulsions in childhood malaria. Trans R Soc Trop Med Hyg 1994 ; 88 : 426-8.
34. Waruiru CM, Newton CRJC, Forster D, New L, Winstanley P, Mwangi I, et al. Epileptic seizures and malaria in Kenyan children. Trans R Soc Trop Med Hyg 1996 ; 90 : 152-5.
35. English M, Waruiru C, Amukoye E, Murphy S, Crawley J, Mwangi I, et al. Deep breathing in children with severe malaria: indicator of metabolic acidosis and poor outcome. Am J Trop Med Hyg 1996 ; 55 : 521-4.
36. Crawley J, English M, Waruiru C, Mwangi I, Marsh K. Abnormal respiratory patterns in childhood cerebral malaria. Trans R Soc Trop Med Hyg 1998 ; 92 : 305-8.
37. Newton CRCJ, Crawley J, Sowunmi A, Waruiru C, Mwangi I, English M, et al. Intracranial hypertension in Africans with cerebral malaria. Arch Dis Child 1997 ; 76 : 219-26.
38. Boele van Hensbroek M, Palmer A, Jaffar S, Schneider G, Kwiatkoswski D. Residual neurologic sequelae after childhood cerebral malaria. J Fed 1997 ; 131 : 125-9.
39. Walker O, Salako LA, Sowunmil A, Thomas JO, Sodeine O, Bondi FS. Prognostic risk factors and post-mortem findings in cerebral malaria in children. Trans R Soc Trop Med Hyg 1992 ; 86 : 491-3.
40. Lucas SB, Hounnou A, Bell J, Peacock C, Andoh J, Honde M, et al. Severe cerebral swelling is not observed in children dying of malaria. Q J Med 1996 ; 89 : 351-3.
41. Brewster DR, Kwiatkowski D, White NJ. Neurological sequelae of cerebral malaria in children. Lancet 1990 ; 336 : 1039-43.
42. Carme B, Bouquety JC, Plassart H. Mortality and sequelae due to cerebral malaria in African children in Brazzaville. Am J Trop Med Hyg 1993 ; 48 : 216-21.
43. Muntendam AH, Jaffar S, Bleichredt N, Boele van Hensbroek. Absence of neuropsychological sequelae following cerebral malaria in Gambian children. Trans R Soc Trop Med Hyg 1996 ; 90 : 391-4.
44. Warhust DC, Williams JE. Laboratory diagnosis of malaria. J Clin Pathol 1996 ; 49 : 533-8.
45. Makler MT, Palmer CJ, Ager AL. A review of practical techniques for the diagnosis of malaria. Ann Trop Med Parasitol 1998 ; 92 : 419-33.
46. Gendrel D, Kombila M, Martz M, Nardou M, Lecointre C, Gendrel C, et al. Parasitémie au cours des accès palustres à Plasmodium falciparum chez l'enfant. Presse Méd 1992 ; 21 : 1805-8.
47. Fialon P, Macaigne F, Becker M, Boisseau MR, Cazenave J, Ripert Ch. Aspects hématologiques du paludisme d'importation. Intérêt diagnostique dans les formes pauci-parasitaires. Pathol Biol 1991 ; 39 : 122-5.
48. Okitolonda W, Delacollette C, Malengreau M, Henquin JC. High incidence of hypoglycemia in African patients treated with intraveinous quinine for severe malaria. Br Med J 1987 ; 295 : 716-8.
49. White NJ, Marsh K, Turner RC, Miller KD, Berry CD, Williamson DH, et al. Hypoglycemia in African children with severe malaria. Lancet 1987 ; 1 : 708-11.
50. Taylor TE, Molyneux ME, Wirima JJ, Fletcher A, Morris K. Blood glucose levels in Malawian children before and during the administration of intraveinous quinine for severe falciparum malaria. N Eng J Med 1988 ; 319 : 1040-7.
51. Kawo NG, Msengi AE, Swai ABM, Chuwa LM, Alberti KGMM, McLarty DG. Specificity of hypoglycaemia for cerebral malaria in children. Lancet 1990 ; 336 : 454-7.
52. English MC, Waruiru C, Lightowler C, Murphy SA, Kirigha G, Marsh K. Hyponatraemia and dehydration in severe malaria. Arch Dis Child 1996 ; 74 : 201-5.
53. Taylor TE, Borgstein A, Molyneux ME. Acid-base status in paediatric Plasmodium falciparum malaria. Q J Med 1993 ; 86 : 99-109.
54. Krishna S, Waller DW, Ter Kuile F, Kwiatkowski D, Crawley J, Craddock CFC, et al. Lactic acidosis and hypoglycaemia in children with severe malaria: pathophysiology and prognostic significance. Trans R Soc Trop Med Hyg 1994 ; 88 : 67-73.
55. Newton CRCJ, Chokwe T, Schellenberg JA, Winstanley PA, Forster D, Peshu N, et al. Coma scales for children with severe falciparum malaria. Trans R Soc Trop Med Hyg 1997 ; 91 : 161-5.
56. Lee LH, Caserta MT. Malaria: update on treatment. Pediatr Infect Dis J 1998 ; 17 : 342-3.
57. Gendrel D, Badoual J, Lagardère B, Bégué P, Richard-Lenoble D. Traitement de l'accès palustre de l'enfant. Arch Fr Pédiatr 1991 ; 48 : 727-35.
58. White NJ. The treatment of malaria. N Eng J Med 1996 ; 335 : 800-6.
59. Spencer H, Kaseje DCO, Brandling-Bennett AD, Oloo AJ, Watkins WM. Epidemiology of chloroquine-associated pruritus in Saradidi, Kenya. Ann Trop Med Parasitol 1987 ; 81 : 124-7.
60. Delmont J, Makando Y, Monges P, Testa J. Prévalence du prurit aux amino-4-quinoléine. Étude par sondage en grappe dans la population d'une ville centrafricaine. Med Trop 1990 ; 50 : 215-20.
61. Coulaud JP, Le Bras J, Matheron S, Morinière B, Saimot AG, Rossignol JF. Treatment of imported cases of falciparum malaria in France with halofantrine. Trans R Soc Trop Med Hyg 1986 ; 80 : 615-6.
62. Watkins WM, Lury JD, Kariuki D, Koech DK, Oloo JA, Mosoba M, et al. Efficacy of multiple-dose halofantrine in treatment of chloroquine-resistant falciparum malaria in children in Kenya. Lancet 1988 ; ii : 247-50.
63. Wirima J, Molyneux M, Khoromana C, Gilles HM. Clinical trials with halofantrine hydrochloride in Malawi. Lancet 1988 ; ii : 250-2.
64. Richard-Lenoble D, Kombila M, Martz M, Gendrel D, Gendrel C, Moreno JL, et al. Efficacy, safety and acceptability of halofantrine in the treatment of acute Plasmodium falciparum malaria in African children (Gabon). J Trop Pediatr 1992 ; 38 : 7-11.
65. Nosten F, Ter Kuile FO, Luxemburger C, Woodrow C, Kyle DE, Chongsuphajaisiddhii T, et al. Cardiac effects of antimalarial treatment with halofantrine. Lancet 1993 : 341 : 1054-6.
66. WHO. Drug alert: halofantrine. Wkly Epidemiol Rec 1993 ; 68 : 269-70.
67. Matson PA, Luby SP, Redd SC, Rolka HR, Meriwether RA. Cardiac effects of standard-dose halofantrine therapy. Am J Trop Med Hyg 1996 ; 54 : 229-31.
68. Sowunmi A, Falade CO, Oduola AMJ, Ogundahunsi OAT, Fehintola FA, Gbotosho GO, et al. Cardiac effects of halofantrine in children suffering from acute uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg 1998 ; 92 : 446-8.
69. Zucker JR, Campbell CC. Malaria. Principles of prevention and treatment. Infect Dis Clin North Am 1993 ; 7 : 547-67.
70. Slutsker LM, Khoromana CO, Payne D, Allen CR, Wirima JJ, Heymann DL, et al. Mefloquine therapy for Plasmodium falciparum malaria in children under 5 years of age in Malawi: in vivo/in vitro efficacy and correlation of drug concentration with parasitological outcome. Bull WHO 1990 ; 68 : 53-9.
71. Ter Kuile FO, Nosten F, Luxemburger C, Kyle D, Teja-Isavatharm P, Phaipun L, et al. Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3 673 patients. Bull WHO 1995 ; 73 : 631-42.
72. Luxemburger C, Price RN, Nosten F, Ter Kuile FO, Chongsuphajaisiddhi T, White NJ. Mefloquine in infants and young children. Ann Trop Paediatr 1996 ; 16 : 281-6.
73. Badoual J. Le traitement du paludisme de l'enfant en France. Pédiatrie 1992 ; 47 : 365-70.
74. Rogier C, Brau R, Tall A, Cisse B, Trape JF. Reducing the oral quinine-quinidine-cinchonin (Quinimax®) treatment of uncomplicated malaria to three days does not increase the recurrence of attacks among children living in a highly endemic area of Senegal. Trans R Soc Trop Med Hyg 1996 ; 90 : 175-8.
75. Kremsner PG, Winkler S, Brandts C, Neifer S, Bienzle U, Graninger W. Clindamycin in combination with chloroquine or quinine is an effective therapy for uncomplicated Plasmodium falciparum malaria in children from Gabon. J Infect Dis 1994 ; 169 : 467-70.
76. Steele RW. Malaria in children. Adv Pediatr Inf Dis 1997 ; 12 : 325-49.
77. Anabwani GM, Esamai FO, Menya DA. A randomised controlled trial to assess the relative efficacy of chloroquine, amodiaquine, halofantrine, and Fansidar® in the treatment of uncomplicated malaria in children. East Afr Med J 1996 ; 73 : 155-9.
78. Olliaro P, Nevill C, Le Bras J, Ringwald P, Mussano P, Garner P, et al. Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet 1996 ; 348 : 1196-201.
79. Brandts CH, Ndjave M, Graninger W, Kremnser PG. Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet 1997 ; 350 : 704-9.
80. Krishna S, Pukrittakamenee S, Suparanond W, Ter Kuile F, Ruprah M, Sura T, et al. Fever in uncomplicated Plasmodium falciparum malaria: randomized double-"blind" comparison of ibuprofen and paracetamol treatment. Trans R Soc Trop Med Hyg 1995 ; 89 : 507-9.
81. Di Piazza, Durand R, Vaslin L, Keudjian A, Longuet C, Pradines B, et al. Chimiosensibilité du paludisme d'importation à Plasmodium falciparum en France en 1997. BEH 1998 ; 33 : 141-2.
82. Recommandations sanitaires pour les voyageurs. BEH 1998 ; 21 : 85-90.
83. Anonymous. Halofantrine in the treatment of malaria. Lancet 1989 ; i : 537-8.
84. Touze JE, Fourcade L, Peyron F, Heno P, Deharo JC. Is halofantrine still advisable in malaria attacks? Ann Trop Med Parasitol 1997 ; 91 : 867-73.
85. Touze JE, Bernard J, Keundjian A, Imbert P, Viguier A, Chaudet H, et al. Electrocardiographic changes and halofantrine plasma level during acute falciparum malaria. Am J Trop Med Hyg 1996 ; 54 : 225-8.
86. Von Seidlein L, Jaffar S, Greenwood B. Prolongation of the QTc interval in children treated for falciparum malaria. Am J Trop Med Hyg 1997 ; 56 : 494-7.
87. Rosenthal PJ, Petersen C, Geertsma FR, Khol S. Availability of intraveinous quinidine for falciparum malaria. N Engl J Med 1996 ; 1 : 138.
88. Hachfi-Soussi F, Coudert V, Biron R, Barois A. Intoxication aiguë à la quinine traitée par diazépam à fortes doses. Arch Fr Pédiatr 1993 ; 50 : 485-8.
89. Jacqz-Aigrain E, Bennasr S, Desplanques L, Peralma A, Beaufils F. Les risques d'intoxication grave liés à l'administration intraveineuse de quinine. Arch Pédiatr 1994 ; 1 : 14-9.
90. Phillips RE, Solomon T. Cerebral malaria in children. Lancet 1990 ; 336 : 1355-60.
91. Hall A. Dangers of high-dose quinine and overhydratation in severe malaria. Lancet 1985 ; i : 1453.
92. White NJ. Optimal regimens of parenteral quinine. Trans R Soc Trop Med Hyg 1995 ; 89 : 462-3.
93. Winstanley PA, Pasvol G, Marsh K. Quinine dose recommendations in childhood malaria-a reply. Trans R Soc Trop Med Hyg 1995 ; 89 : 463-4.
94. Pasvol G, Newton CRJC, Winstanley PA, Watkins WM, Peshu NM, Were JBO, et al. Quinine treatment of severe falciparum malaria in African children: a randomized comparison of three regimens. Am J Trop Med Hyg 1991 ; 45 : 702-13.
95. Winstanley P, Newton C, Watkins W, Mberu E, Ward S, Warn P, et al. Towards optimal regimens of parenteral quinine for young African children with cerebral malaria: the importance of unbound quinine concentration. Trans R Soc Trop Med Hyg 1993 ; 87 : 201-6.
96. Boele Van Hensbroek M, Kwiatkowski D, Van den Berg B, Hoek FJ, Van Boxtel CJ, Kager PA. Quinine pharmacocinetics in young children with severe malaria. Am J Trop Med Hyg 1996 ; 54 : 237-42.
97. Davis TME, Supanaranond W, Pukrittayakamee S, Karbwang J, Molunto P, Mekhton S, et al. A safe and effective consecutive-infusion regimen for rapid quinine loading in severe falciparum malaria. J Infect Dis 1990 ; 161 : 1305-8.
98. Miller KD, Greenberg AE, Campbell CC. Treatment of severe malaria in the United States with a continuous infusion of quinidine gluconate and exchange transfusion. N Eng J Med 1989 ; 321 : 65-70.
99. Mordmuller B, Kremnser PG. Hyperparasitemia and blood exchange transfusion for treatment of children with falciparum malaria. Clin Inf Dis 1998 ; 26 : 850-2.
100. Warrell DA, Looareesuwan S, Warrell MJ, Kasemsarn P, Intaraprasert R, Bunnag D, et al. Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients. N Engl J Med 1982 ; 306 : 313-9.
101. Hoffman SL, Rustama D, Punjabi NH, Surampaet B, Sanjaya B, Dimpudus AJ, et al. High-dose dexamethasone in quinine-treated patients with cerebral malaria: a double-blind, placebo-controlled trial. J Infect Dis 1988 ; 158 : 325-31.
102. Winstanley PA, Newton CRCJ, Pasvol G, Kirkham FJ, Mberu E, Peshu N, et al. Prophylactic phenobarbitone in young children with severe falciparum malaria: pharmacocinetics and clinical effects. Br J Clin Pharmac 1992 ; 33 : 149-54.
103. Kremnser PG, Radloff P, Metzger W, Wildling E, Mordmuller B, Phillips J, et al. Quinine plus Clindamycin improves chemotherapy of severe malaria in children. Antimicrob Agents Chemother 1995 ; 39 : 1603-5.
104. Krishna S, Supanaranond W, Pukrittayakamee S, Karter D, Supputamongkol Y, Davis TME, et al. Dichloroacétate for lactic acidosis in severe malaria: a pharmacokinetic and pharmacodynamic assessment. Metabolism 1994 ; 43 : 974-81.
105. English M, Waruiru C, Marsh K. Transfusion for respiratory distress in life-threatening childhood malaria. Am J Trop Med Hyg 1996 ; 55 : 525-30.
106. Gordeuk V, Thuma P, Brittenham G, Mc Laren C, Parry D, Backenstose A, et al. Effect on iron chelation therapy on recovery from deep coma in children with cerebral malaria. N Engl J Med 1992 ; 327 : 1473-7.
107. Di Perri G, Guasparri Di Perri H, Badona Monteiro G, Bonora S, Hennig C, Cassatella M, et al. Pentoxifylline as a supportive agent in the treatment of cerebral malaria in children. J Infect Dis 1995 ; 171 : 1317-22.
108. Walker O, Salkako LA, Omokhodion SI, Sowunmi A. An open randomized comparative study of intramuscular arthemeter and intraveinous quinine in cerebral malaria in children. Trans R Soc Trop Med Hyg 1993 ; 87 : 564-6.
109. Murphy S, English M, Waruiru C, Mwangi I, Amukoye E, Crawley J, et al. An open randomized trial of artemether versus quinine in the treatment of cerebral malaria in African children. Trans R Soc Trop Med Hyg 1996 ; 90 : 298-301.
110. Taylor TE, Wills BA, Courval JM, Molyneux ME. Intramuscular artemether vs intraveinous quinine: an open randomized trial in Malawian children with cerebral malaria. Trop Med Int Health 1998 ; 3 : 3-8.
111. Boele Van Hensbroek M, Onyiorah E, Jaffar S, Schneider G, Palmer A, Frenkel J, et al. A trial of artemether or quinine in children with cerebral malaria. N Engl J Med 1996 ; 335 : 69-75.
112. Santin A, Semaille C, Prazuck T, Bargain P, Lafaix C, Fisch A. Chimioprophylaxie anti-paludique des voyageurs français (n = 3 446) au départ de Paris pour huit destinations tropicales. BEH 1998 ; 19 : 78-79.
113. Steffen R, Heusser R, Machler R, Bruppacher R, Naef U, Chen D, et al. Malaria chemoprophylaxis among European tourists in tropical Africa: use, adverse reactions and efficacy. Bull WHO 1990 ; 68 : 313-22.
114. WHO. Malaria chemoprophylaxis regimens for travellers. Wkly Epidemiol Rec 1993 ; 51 : 377-83.
115. er janvier 1994. Genève OMS 1994. 104 p.
116. Carme B. Mesures antipalustres chez les expatriés au Congo. Tendances 1989-1992. Ann Soc Belge Med Trop 1993 ; 73 : 91-9.
117. Bem JL, Kerr L, Stuerchler D. Mefloquine prophylaxis: an overview of spontaneous reports of severe psychiatric reactions and convulsions. J Trop Med Hyg 1992 ; 95 : 167-79.
118. Conlon CP, Berendt AR, Dawson K, Peto TEA. Runway malaria. Lancet 1990 ; 335 : 472-3.
119. D'alessandro U, Olaleye BO, McGuire W, Thomson MC, Langerock P, Bennett S, et al. A comparison of the efficacy of insecticide-treated and untreated bed nets in preventing malaria in Gambian children. Trans R Soc Trop Med Hyg 1995 ; 89 : 596-8.
120. Choi HW, Breman JG, Teutsch SM, Liu S, Hightower AW, Sexton JD. The effectiveness of insecticide-impregnated bed nets in reducing cases of malaria infection: a meta-analysis of published results. Am J Trop Med Hyg 1995 ; 52 : 377-82.
121. Combemale P, Deruaz D, Villanova D, Guillaumont P. Ann Dermatol Vénéréol 1992 ; 119 : 411-34.
122. Lipscomb JW, Kramer JE, Leikin JB. Seizure following brief exposure to the insect repellent N,N-diethyl-m-toluamide. Ann Emerg Med 1992 ; 21 : 315-7.
123. Edwards DL, Johnson CE. Insect-repellent-induced toxic encephalopathy in a child. Clin Pharm 1987 ; 6 : 496-8.
124. Brown M, Hebert AA. Insects repellents: an overview. J Am Acad Dermatol 1997 ; 36 : 243-9.
125. Osimitz TG, Murphy JV. Neurological effects associated with use of the insect repellent N,N-diethyl-m-toluamide (DEET). Clin Toxicol 1997 ; 35 : 435-41.
126. Selvaag E. Chloroquine-induced vitiligo-like depigmentation. Ann Trop Paediatr 1997 ; 17 : 45-8.
127. Croft A, Garner P. Mefloquine to prevent malaria: a systematic review of trials. BMJ 1997 ; 315 : 1412-6.
128. Mc Bride SR, Lawrence CM, Pape SA, Reid CA. Fatal toxic epidermal necrolysis associated with mefloquine antimalarial prophylaxis. Lancet 1997 ; 349 : 101.
129. Clattenburg RN, Donnelly CG. Case study: neuropsychiatric symptoms associated with the antimalarial agent mefloquine. J Am Acad Child Adolesc Psychiatry 1997 ; 36 : 1606-8.
130. Lagardère B, Gay F. Résistance du paludisme de l'enfant en France. Journées parisiennes de pédiatrie. Paris : Flammarion Médecine-Sciences ; 1993.
131. Lell B, Luckner D, Ndjave M, Scott T, Kremsner PG. Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children. Lancet 1998 ; 351 : 709-13.
132. Sadiq ST, Glasgow KW, Drakeley CJ, Muller O, Greenwood BM, Mabey DCW, et al. Effects of azithromycin on malariometric indices in the Gambia. Lancet 1995 ; 346 : 881-2.
133. Walter EB, Clements DA. Travel consultation for children in a university-affiliated primary care setting. Ped Infect Dis J 1998 ; 17 : 841-3.